Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study

Journal Title: Medpulse International Journal of Pharmacology - Year 2019, Vol 10, Issue 2

Abstract

Background:Metformin and Vildagliptin have independent glucose-lowering properties and may increase GLP-1 levels by working through complementary mechanisms. The combination of metformin and glimepiride is a well-established therapy for type 2 DM.Aim: To compare the efficacy and safety of vildagliptin-metformin and glimepiride-metformin treatment in type 2 diabetic patients.Material and Methods:Patients was randomly assigned in (1:1) ratio after randomization to either of two groups (35 in each group), one group prescribed glimepiride(1mg) +metformin (500mg) twice daily half an hour before meals and other group vildagliptin(50mg)+ metformin(500mg) twice daily half an hour before meals. HbA1c, FBS, PPBS was repeated at the end of 3rd month.Results:The mean HbA1c levels at baseline (0 weeks) were 8.80 ±0.62and 8.99 ±0.37 in Group A and Group B respectively. Similarly, at 12 weeks mean HbA1c levels were 6.47±0.44 and 6.42±0.42 in Group A and Group B respectively. The change in percentage of HbA1c at 12 weeks was -26.06% and -27.86% in Group A and Group B respectively but no statistical significance different was found. (P=0.26). The HbA1c levels < 7 were achieved among 29 (41.43%) subjects in Group A as compared to 28 (40%) subjects in Group B.The difference between HbA1c levels among study groups was not statistically significant. (P=0.75).Conclusion:The efficacy and tolerability of vildagliptin, was similar, with no significant differences, when used to treat type 2 diabetic patients with inadequate blood glucose control by dual combination of metformin and glimepiride.

Authors and Affiliations

P KalaiSelvi, D Nishanthini

Keywords

Related Articles

Evaluation of knowledge, attitude and practice of adverse drug reaction reporting among registrars and consultants in a tertiary care hospital

Background: Spontaneous reporting is considered the main mechanism in the pharmacovigilance system by which the adverse drug reactions are identified after the drug is released onto the market. However, pharmacovigilance...

Prescription pattern of antibiotics in the skin and soft tissue infections in patients with diabetes mellitus: Experience from a tertiary care teaching hospital

Objectives: To report the clinical presentation of various skin and soft tissue infections, antimicrobial therapy and the outcomeofin diabetic patients.Methods: A retrospective descriptive study. Results: The prescriptio...

A prospective study of drug utilization in patients undergoing cataract surgery

Background: Drug utilization studies are an important part of rational use of drugs. Assessment of drug use pattern especially in developing countries is becoming increasingly necessary to promote the rational use of dru...

Prescription pattern of fixed dose drug combination in psychiatry out-patient department

Background: Fixed dose combinations are one of the strategies to reduce the number of drugs prescribed and improve medical compliance. Increased requirement of drugs in patients with more than one disease justifies the u...

Effect of glimepride and metformin as a monotherapy on lipid profile in T2DM patients

Aims and Objective: To compare effect of glimepride and metformin alone on lipid profile in T2DM patients Material and Methods: T2DM patients having duration of less than 5 years were randomly selected and grouped in to...

Download PDF file
  • EP ID EP615747
  • DOI 10.26611/10101022
  • Views 95
  • Downloads 0

How To Cite

P KalaiSelvi, D Nishanthini (2019). Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study. Medpulse International Journal of Pharmacology, 10(2), 14-18. https://europub.co.uk/articles/-A-615747